Latest Leadership Change News

Marquee Resources has progressed its Mt Clement antimony-gold project with Phase 1 drilling completed and assay results pending, alongside a $596,000 capital raise and a key executive appointment.

QEM Limited has appointed Robert Cooper as its new CEO and secured $2.05 million in funding, while progressing key regulatory and technical milestones for its Julia Creek Vanadium and Energy Project.

Mithril Silver and Gold Limited reports strong exploration progress in Mexico’s Copalquin District with high-grade gold and silver assay results and a successful C$11.5 million private placement.

Ramelius Resources has finalized its acquisition of Spartan Resources, issuing new shares and cash to Spartan shareholders while expanding its board and asset portfolio. This move aims to accelerate Ramelius' growth toward becoming a half-million ounce gold producer within five years.

Lord Resources announces the resignation of CEO Andrew Taylor as exploration at the Ilgarari Copper Project advances under Georgina Clark’s management.

InteliCare Holdings advances its AI-driven aged care platform with new trials and integrations, secures $1 million in funding, and announces CEO Daniel Pilbrow’s upcoming resignation.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.

Janus Electric Holdings has relaunched on the ASX, securing $8.8 million to accelerate its heavy vehicle electrification strategy, including a key supply agreement with Electrovaya for next-generation lithium-ion batteries.

American Rare Earths Limited reports strong progress at its Halleck Creek Rare Earths Project, highlighted by exceptional sampling results, key permitting milestones, and a $15 million equity raise to fund development.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

Indiana Resources has reported significant extensions of high-grade gold mineralisation at its Minos prospect within the Gawler Craton Project, alongside a proposed capital return and key executive appointments to drive future growth.